Related Experiment Video
Updated: Jan 25, 2026

Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
Mesenchymal Stem Cell Capping on ECM-Anchored Caspase Inhibitor-Loaded PLGA Microspheres for Intraperitoneal
Shiva Pathak1, Shobha Regmi1, Prakash Shrestha1
1College of Pharmacy, Yeungnam University, Gyeongsan, Gyeongbuk, 38541, Republic of Korea.
Abstract:
Mesenchymal stem cells (MSCs) are considered as a promising alternative for the treatment of various inflammatory disorders. However, poor viability and engraftment of MSCs after transplantation are major hurdles in mesenchymal stem cell therapy. Extracellular matrix (ECM)-coated scaffolds provide better cell attachment and mechanical support for MSCs after transplantation. A single-step method for ECM functionalization on poly(lactic-co-glycolic acid) (PLGA) microspheres using a novel compound, dopamine-conjugated poly(ethylene-alt-maleic acid), as a stabilizer during the preparation of microspheres is reported. The dopamine molecules on the surface of microspheres provide active sites for the conjugation of ECM in an aqueous solution. The results reveal that the viability of MSCs improves when they are coated over the ECM-functionalized PLGA microspheres (eMs). In addition, the incorporation of a broad-spectrum caspase inhibitor (IDN6556) into the eMs synergistically increases the viability of MSCs under in vitro conditions. Intraperitoneal injection of the MSC-microsphere hybrid alleviates experimental colitis in a murine model via inhibiting Th1 and Th17 differentiation of CD4+ T cells in colon-draining mesenteric lymph nodes. Therefore, drug-loaded ECM-coated surfaces may be considered as attractive tools for improving viability, proliferation, and functionality of MSCs following transplantation.
Insights
Mesenchymal stem cells (MSCs) show promise for inflammatory disorders, but poor survival hinders therapy. ECM-functionalized microspheres enhance MSC viability and function, offering a potential therapeutic advance.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Immunology
Background:
- Mesenchymal stem cells (MSCs) are a promising therapeutic for inflammatory disorders.
- Poor MSC viability and engraftment limit their clinical application.
- Extracellular matrix (ECM)-coated scaffolds can improve MSC survival and integration.
Purpose of the Study:
- To develop ECM-functionalized poly(lactic-co-glycolic acid) (PLGA) microspheres for enhanced MSC transplantation.
- To evaluate the effect of ECM coating and caspase inhibition on MSC viability.
- To assess the therapeutic efficacy of MSC-microsphere constructs in a murine colitis model.
Main Methods:
- A single-step method for ECM functionalization of PLGA microspheres using dopamine-conjugated poly(ethylene-alt-maleic acid).
- In vitro assessment of MSC viability on ECM-functionalized microspheres (eMs), with and without a caspase inhibitor (IDN6556).
- In vivo evaluation of MSC-microsphere hybrid treatment in a murine model of experimental colitis.
Main Results:
- ECM functionalization of PLGA microspheres (eMs) improved MSC viability.
- Co-incorporation of a caspase inhibitor (IDN6556) synergistically enhanced in vitro MSC viability.
- Intraperitoneal injection of MSC-microsphere hybrids reduced colitis severity by inhibiting Th1 and Th17 cell differentiation.
Conclusions:
- ECM-functionalized microspheres offer a viable strategy to improve MSC survival and therapeutic potential.
- Combining ECM coating with caspase inhibition further enhances MSC viability.
- This approach holds promise for treating inflammatory diseases like colitis.
Related Concept Videos
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
The Anchoring-and-Adjustment Heuristic
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Caspases

